Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.
D000208:Acute Disease; D000818:Animals; D001168:Arthritis / Q000209:etiology; D002908:Chronic Disease; D003165:Complement System Proteins / Q000032:analysis*; D005260:Female; D006505:Hepatitis / Q000276:immunology; D006506:Hepatitis A / Q000150:complications / Q000276:immunology / Q000382:microbiology; D006511:Hepatitis B Antigens; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D008105:Liver Cirrhosis, Biliary / Q000276:immunology; D008107:Liver Diseases / Q000276:immunology*; D008297:Male; D010587:Phagocytosis; D011817:Rabbits / Q000276:immunology
D006511:Hepatitis B Antigens; D003165:Complement System Proteins